Drug research

Human Acellular Vessel (HAV)

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as (regulated as a biological product)

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for HemodialysisNCT02644941	HUMA	Phase 3	Completed	2019-05Actual
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for HemodialysisNCT03183245	HUMA	Phase 3	Completed	2024-04-22Actual
Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PADNCT02887859	HUMA	Phase 2	Completed	2020-12Actual

HUMACompletedPrimary completion: 2019-05 · Actual

Trial details

HUMACompletedPrimary completion: 2024-04-22 · Actual

Trial details

HUMACompletedPrimary completion: 2020-12 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.